Last reviewed · How we verify
NCT06611215
Effect of a Nutritional Supplement on Gut Microbiota in Adults
NA trial testing Treatment in Changes in Gut Microbiota with Prebiotic Supplementation in 80 participants. Not yet recruiting.
7 April 2025
Quick facts
| Lead sponsor | Pharmavite LLC |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 80 |
| Start date | 23 September 2024 |
| Primary completion | 7 April 2025 |
| Estimated completion | 2 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
Conditions studied
- Changes in Gut Microbiota with Prebiotic Supplementation — all drugs for Changes in Gut Microbiota with Prebiotic Supplementation →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Pharmavite LLC — full company profile →
Who can join
Adults 18 to 60, any sex, with Changes in Gut Microbiota with Prebiotic Supplementation or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to International Scientific Association for Probiotics and Prebiotics (ISAPP), a prebiotic is defined as a substrate that is selectively utilized by host microorganisms conferring a health benefit (Gibson et al, 2017). Fibers/ Prebiotics are known to have several beneficial effects on human health via gut. They remain mostly undigested in upper GI and reach colon where they are fermented by resident gut microbiota. This leads to the production of several beneficial metabolites such as short chain fatty acids and others which are implied in human health. The aim of this study is to examine the effects of combinations of two prebiotics on gut microbiota modulation and Quality of Life at two doses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06611215
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Treatment
Trials testing the same drug.
- NCT07322211 — A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses · NA · recruiting
- NCT07339553 — Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Ep · Phase 2 · not yet recruiting
- NCT07239622 — Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Ce · Phase 2 · not yet recruiting
- NCT06935240 — Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity · NA · recruiting
- NCT07176234 — The LEADS Trial (Linking Exericise for Advancing Daily Stress Management) · NA · recruiting
Other Pharmavite LLC trials
Trials by the same sponsor.
- NCT06935123 — Impact of Nutritional Supplementation on Sleep Quality · Phase 1 · completed
- NCT06837246 — A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population · NA · recruiting
- NCT06058364 — Effect of a Nutritional Supplement on Mental Wellness in Adults · NA · completed
- NCT04067791 — A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melat · Phase 1 · completed
- NCT04516304 — A Nutritional Supplement on Vasomotor Symptoms in Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06611215 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pharmavite LLC
- Last refreshed: 24 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611215.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing